Metabolic effects of carnitine and its role in medicine;Metabolické účinky karnitinu a jeho význam v medicíně

Klinicka Biochemie a Metabolismus

Volumn 13, Issue 1, 2005, Pages 24-28

  Cibulka, Roman ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

oxidation of fatty acids; Carnitine; Carnitine deficiency; Carnitine metabolism; Carnitine supplementation

Indexed keywords

CARNITINE; COENZYME A; FRUCTOKINASE; GLUCOSE; PYRUVATE DEHYDROGENASE COMPLEX;

BRAIN; CARNITINE DEFICIENCY; DRUG EFFECT; DRUG METABOLISM; ENERGY METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HUMAN; KIDNEY; LIVER; MITOCHONDRIAL MEMBRANE; REVIEW;

EID: 22444440084     PISSN: 12107921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Tomita, M., Sendju, Y. Ueber die Oxyaminoverbindungen welche die Biuretreaktion zeigen. Z. physiol. Chem., 1927, 196, s. 263-267.
2. Friedmann, S., Fraenkel, G. Reversible enzymatic acetylation of carnitine. Arch. Biochem. Biophys, 1955, 59, p. 491-501.
3. Battistella, P. A., Angelini, C., Vergani, L., Bertoli, M., Lorenzi, S. Carnitine deficiency induced during hemodialysis. Lancet, 1978, p. 939.
4. Bohmer, T., Bergrem, H., Eiklid, K. Carnitine deficiency induced during intermitent haemodialysis for renal failure. Lancet, 1978, p. 126-128.
5. Ahmad, S., Robertson, H. T., Golper, T. A., Wolfson, M. et al. Multicenter trial of L-carnitine in maintenance hemodialysis patients (II). Clinical and biochemical effects. Kidney Int., 1990, 38, p. 912-918.
6. Steidl, L., Zbránková, B. Význam karnitinu a jeho použití v medicíně. Praha: Triton 2000, s. 7, 10-11.
7. Regitz, V., Paulson, D. J., Noonan, J., Fleck, E., Shug A. L. Protection of the ischemic myocardium by propionyl carnitine taurine amid. Comparision with other carnitine derivatives. Z. Kardiol., 1987, 76, s. 53-58.
8. Murray, R. K., Granner, D. K., Mayes, P. A., Rodwell, V. W. Harperova biochemie. Praha: HaH 1998, 232 s.
9. McGarry, J. D., Brown, N. F. The mitochondrial carnitine palmitoyl transferase system. From concept to molecular analysis. Eur. J. Biochem., 1997, 244, p. 1-14.
10. Wanders, R. J., Vreken, P., Ferdinandusse, S. Peroxisomal fatty acid α- and β-oxidation in humans: Enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem. Soc. Trans., 2001, 29, p. 250-267.
11. Vaz, F. M., Wanders, R. Carnitine homeostasis and human disease: Advances in metabolite analysis. LabMedica, 2002, 19, p. 14-17.
12. Schonekess, B. O., Allard, M. F., Lopaschuk, G. D. Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circulation Research, 1995, 77, p. 726-734.
13. Bremer, J. Carnitine-metabolism and functions. Physiol. Rev., 1983, 63, p. 1420-1480.
14. Vaz, F. M., van Gool, S., Ofman, R., Ijlst, L., Wanders, R. J. Carnitine biosynthesis: Identification of the cDNA encoding human γ-butyrobetaine hydroxylase. Biochem. Biophys. Res. Commun., 1998, 250, p. 506-510.
15. Prasad, P. D., Huang, W., Ramamoorthy, S., Carter, A. L., Leibach, F. H., Gamapathy, V. Sodium dependent carnitine transport in human placental choriocarcinoma cells. Biochem. Biophys. Acta, 1996, p. 109-117.
16. Wagenmakers, A. L-carnitine supplementation and performance in man. Medicine Sport Sci., 1991, 32, p. 110-127.
17. Ferrari, R., Di Mauro, S., Sherwood, G. L-carnitine and its role in medicine: From function to therapy. London: Academia Press 1992.
18. Kolář, F. Carnitine and cardial diseases. Cor Vasa, 1994, 36, p. 190-198.
19. Shug, A. L., Subramanian, R. Modulation of adenine nucleotide translocase activity during myocardial ischemia. Z. Kardiol., 1987, 75, p. 26-33.
20. Hou, J. W. Primary systemic carnitine deficiency presenting as reccurent Reye-like syndrome and dilated cardiomyopathy. Chang Gung Med. J., 2002, 25, 12, p. 832-837.
21. Rebouche, C. J., Engel, A. G. Carnitine metabolism and deficiency syndromes. Mayo Clin. Proc., 1983, 58, 8, p. 533-540.
22. Breningstall, G. N. Carnitine deficiency syndromes. Pediatr. Neurol., 1990, 6, 2, p. 75-81.
23. Di Mauro, S., Trevisan, C., Hays, A. Disorders of lipid metabolism in muscle. Muscle Nerve, 1980, 3, 5, p. 369-388.
24. Karmaniolas, K., Ionnidis, P., Liatis, S., Dalamanga, M., Papalambros, T., Migdalis, I. Primary carnitine deficiency in a male adult. J. Med., 2002, 33, 14, p. 105-110.
25. Nezu, J., Tamai, I., Oku, A., Ohashi, R., Yabuuchi, H. et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat. Genet., 1999, 21, p. 91-94.
26. Slama, A., Brivet, M., Boutron, A., Legrand, A., Saudubray, J. M., Demaugre, F. Complementation analysis of carnitine palmitoyltransferase I and II defects. Pediatr. Res., 1996, 40, 4, p. 542-546.
27. Yang, B. Z., Mallory, J. M., Roe, D. S., Brivet, M., Strobel, G. D. et al. Carnitine/acylcarnirine translocase deficiency (neonatal phenotype): successful prenatal and postmortem diagnosis associated with a novel mutation in a single family. Mol. Genet. Metab., 2001, 73, 1, p. 64-70.
28. Steidl, L., Zbránková, B. Význam karnitinu a jeho použití medicine. Praha: Triton 2000, s. 33-35, 101.